David Lillicrap

15.8k citations

324 papers · 9.6k indexed · 1 hit paper · h-index 55

Impact in

Hematology top 0.05%
- Platelet Disorders and Treatments
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Blood groups and transfusion
Internal Medicine top 0.5%

Papers in

Hematology 271
- Platelet Disorders and Treatments 174
- Hemophilia Treatment and Research 159
- Blood Coagulation and Thrombosis Mechanisms 85
- Blood groups and transfusion 68
Genetics 47
- Virus-based gene therapy research 47

Co-authors: Christine Hough Paula James Colleen Notley Paula D. James Andrea Labelle Laura L. Swystun Maha Othman Paul Batty
Journals: Blood (74 papers)Journal of Thrombosis and Haemostasis (58 papers)Haemophilia (42 papers)British Journal of Haematology (18 papers)Thrombosis and Haemostasis (9 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

David Lillicrap

316 papers receiving 9.3k citations

Hit Papers

align trajectories log scale

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders 2010 · 558 citations

Peers

Countries citing papers authored by David Lillicrap

Since Specialization

Citations

This map shows the geographic impact of David Lillicrap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lillicrap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lillicrap more than expected).

Fields of papers citing papers by David Lillicrap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lillicrap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lillicrap. The network helps show where David Lillicrap may publish in the future.

Co-authors

The 25 scholars most cited alongside David Lillicrap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Lillicrap Line = papers co-authored together David Lillicrap links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI Journal of Thrombosis and Haemostasis ·Ferdows Atiq, Orla Rawley, Jamie M. O’Sullivan, Mehmet Özbil, Phoebe Ballard, Diego Abente Brun And, Virginie Terraube, Alain Chion, Shirley Pamela, Claudia G. Guerra-Rojas, S. Strauch, 星野茂, Benjamin Cerkvenik, David Lillicrap, James S. O’Donnell	2024	0
2	Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells Journal of Thrombosis and Haemostasis ·Tiphaine Bardeau, Erin Burnett, Weiyue Xue, Colleen Notley, Nathalie Tijet, Natasha Christie-Holmes, Christine Hough, David Lillicrap	2023	0
3	Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice Cellular Immunology ·Thaís B. Bertolini, Roland W. Herzog, Sandeep Kumar, Alexandra Sherman, Jyoti Rana, Radosław Kaczmarek, Kentaro Yamada, Sreevani Arisa, David Lillicrap, Cox Terhorst, Henry Daniell, Moanaro Biswas	2023	4
4	A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment? Journal of Thrombosis and Haemostasis ·Leonard A. Valentino, Margareth C. Ozelo, Roland W. Herzog, Nigel S. Key, Allyson M. Pishko, Margaret V. Ragni, Benjamin J. Samelson‐Jones, David Lillicrap	2023	11
5	Immune complications and their management in inherited and acquired bleeding disorders Blood ·Valder R. Arruda, David Lillicrap, Roland W. Herzog	2022	10
6	von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells Journal of Thrombosis and Haemostasis ·Mackenzie Bowman, Guilherme Becker Sander, C.Y. Goh, Patrícia Lima, Orla Rawley, Katarzyna Błachowska, Angie Tuttle, Julie Grabell, Alfonso Iorio, Irwin Walker, David Lillicrap, Paula James	2022	7
7	Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis Research and Practice in Thrombosis and Haemostasis ·Michelle Sholzberg, Bruno R. da Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, 余俊卿, Paula James, David Lillicrap, Marc Carrier, Andrew Beckett, Michael Fralick, Saskia Middeldorp, Agnes Lee, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni	2021	30
8	To clot or not to clot? Ad is the question—Insights on mechanisms related to vaccine‐induced thrombotic thrombocytopenia Journal of Thrombosis and Haemostasis ·Maha Othman, Alexander T. Baker, S. Devishree, 汪江宁, Carly M. Bliss, Matthew T. Rondina, David Lillicrap, Alan L. Parker	2021	15
9	The highly prevalent deletions in F8 intron 13 found in French mild hemophilia A patients result from both founder effect and recurrent de novo events Journal of Thrombosis and Haemostasis ·Faustini Leonardo, Y Gietl, Fanny Lassalle, David Lillicrap, Claude Négrier, Christine Vinciguerra	2020	4
10	Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease Journal of Thrombosis and Haemostasis ·Kimberley A. Seward, Mackenzie Bowman, Colleen Notley, Weiyue Xue, Patrícia Lima, Annika de Jong, Richard Dirven, Ester M. Weijers, David Lillicrap, Paula James, Jeroen Eikenboom	2020	20
11	The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays Haemophilia ·Fanny Lassalle, Faustini Leonardo, Loubna Jouan, Laura L. Swystun, Julie Gauthier, C. Zawadzki, Jenny Goudemand, Sophie Susen, Georges‐Étienne Rivard, David Lillicrap	2020	11
12	Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population Journal of Thrombosis and Haemostasis ·Kenichi Ogiwara, Laura L. Swystun, Daniela De Luchi, Flamme Marie, ACSD Buffoni, Indah Kencanawati, Wilma M. Hopman, Ingrid Pabinger, David Lillicrap	2020	10
13	The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen Journal of Thrombosis and Haemostasis ·Laura L. Swystun, Kenichi Ogiwara, Jesse D. Lai, Juha Ojala, Orla Rawley, Fanny Lassalle, Colleen Notley, Xunrong Zhou, Alison Michels, Kate Nesbitt, Karl Tryggvason, David Lillicrap	2019	19
14	Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia Blood ·Richard S. Blumberg, David Lillicrap, (unknown)	2018	28
15	A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a Blood ·Victor S. Blanchette, Zhuliang Zhou, David Lillicrap, Shannon Jackson, Massimo Morfini, Q Z Qin, Manuel Carção, Margaret L. Rand, Derek Stephens, Justin Guilbert, Ester Zápotocká, V. Komrska, Jan Blatný	2018	1
16	Biological considerations of plasma-derived and recombinant factor VIII immunogenicity Blood ·Jesse D. Lai, Christine Hough, TAMARA SHUQUM ROSS, David Lillicrap	2017	35
17	Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease Blood ·Karl C. Desch, Ayse Bilge Ozel, Matthew Halvorsen, Alison Michels, Laura L. Swystun, Lauren E. Mokry, Brent Richards, Marine Germain, David‐Alexandre Trégouët, Pieter H. Reitsma, Clive Kearon, Jun Z. Li, David B. Goldstein, David Lillicrap, David Ginsburg	2017	4
18	Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response Blood ·Margareth C. Ozelo, B. Vidal, Christine Brown, Colleen Notley, Carol Hegadorn, Jodi Acornley, E. М. SHLIAHOV, 顕一郎中島, Andrew Winterborn, Frida Brundin, Valder R. Arruda, Christine Hough, David Lillicrap	2014	23
19	Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study Journal of Thrombosis and Haemostasis ·Brian M. Feldman, Menaka Pai, Georges‐Étienne Rivard, Sara J. Israels, M.‐C. Poon, C. Demers, 张梦芯, K. H. Luke, John K. Wu, 邵迎建, David Lillicrap, Paul Babyn, M. McLimont, Victor S. Blanchette	2006	192
20	Sensitivity of PCR in detecting monoclonal B cell proliferations. Journal of Clinical Pathology ·Alexandru‐Constantin Stoica, Gabriela de Lima Alcântara, W. E. N. Corbett, David Lillicrap	1993	11

About David Lillicrap

David Lillicrap is a scholar working on Hematology, Genetics, Genetics, Internal Medicine and Immunology, having authored 324 papers that have together received 9.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (174 papers), Hemophilia Treatment and Research (159 papers), Blood Coagulation and Thrombosis Mechanisms (85 papers), Blood groups and transfusion (68 papers), Virus-based gene therapy research (47 papers), Cancer-related gene regulation (35 papers), CAR-T cell therapy research (27 papers) and Complement system in diseases (25 papers). The work is most often cited by research in Hematology (6.9k citations), Internal Medicine (553 citations), Genetics (1.4k citations), Genetics (1.9k citations) and Immunology (826 citations). David Lillicrap has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Christine Hough, Paula James, Colleen Notley, Paula D. James, Andrea Labelle, Laura L. Swystun, Maha Othman, Paul Batty, Carol Hegadorn and Francesco Rodeghiero. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Haemophilia, British Journal of Haematology and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact